Topic:

R&D

Latest Headlines

Latest Headlines

U.S. pivotal trial starts for Senseonics glucose monitor implant with data due in June

Upstart Senseonics expects to be the first to introduce a long-term implant to continuously monitor glucose levels in diabetics. It's already under review for a CE mark after disclosing pivotal European data in October. Now, it's detailed the plans for the pivotal U.S. study of its Eversense Continuous Glucose Monitoring System.

GlaxoSmithKline scientists accused of stealing drug R&D secrets for China scheme

Yu Xue had a hard-earned reputation as a top chemist while she was working for GlaxoSmithKline in its Upper Merion, PA, facility. But Yu Xue--better known as Joyce--was also an accomplished thief during the last four years of her 10-year tenure, according to allegations laid out in a federal indictment filed by the U.S. Attorney's office in Eastern Pennsylvania.

Biosimilars developer Celltrion taps Medidata for trial tech

South Korea's Celltrion has recruited Medidata to provide eClinical technology as it works to develop copycat versions of the world's top-selling biological treatments.

GSK, Qualcomm rumored to form $1B med tech JV

GlaxoSmithKline and Qualcomm are in talks to create a joint venture to enable GSK to expand into med tech, according to a report by Bloomberg that cites anonymous people knowledgeable of the matter.

Researchers get stem cells to 'beat' with electrical current, offering hope for heart regeneration

Columbia engineering researchers have found that electrical stimulation of human heart muscle cells, or cardiomyocytes, engineered from human stem cells can beat with electrical stimulation. For the first time, they found that this activity actually encouraged the nascent cardiomyocytes to beat autonomously and to transfer that to surrounding cardiomyocytes.

Automated external defibrillators rarely used to treat cardiac arrest in high-rise buildings: Study

Automated external defibrillator devices can often mean the difference between life and death for individuals who experience cardiac arrest. But in some cases the products are rarely used, according to a new study.

Google's Verily, AHA, AstraZeneca team up for heart disease R&D with $75M

The American Heart Association, Verily (formerly Google Life Sciences) and AstraZeneca have chipped in a total of $75 million over 5 years to support "one brave idea from a visionary leader" to cure coronary heart disease.

NIH, DARPA-backed researchers develop wireless, dissolvable brain sensors

Scientists have developed brain implants to monitor pressure and temperature after traumatic brain injury that dissolve over a few days. The idea is that these could be implanted during surgery on TBI patients in order to conduct subsequent monitoring, but then they would not require removal.

Biden puts data sharing at center of drive to cure cancer

Vice President Joe Biden has put improved data sharing at the center of a government-led initiative to cure cancer. The plan is to create conditions that usher improved drugs to market by working with tech companies to pull down data silos while boosting the resources available to public and private research teams.

BioMed X emerges from Merck KGaA alliance armed with bioinformatics tools

BioMed X has begun offering bioinformatics services on the back of its alliance with Merck KGaA. The services are underpinned by tools developed during BioMed X's three-year collaboration with Merck KGaA, during which it advanced computational approaches to the design of highly selective kinase inhibitors.
'